-
2023.09.05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
-
2023.08.28
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
-
2023.08.16
DATE OF BOARD MEETING
-
2023.08.07
VOLUNTARY ANNOUNCEMENT
COMPLETION OF THE FIRST FEE-FOR-SERVICE
COMPASSIONATE USE TREATMENT WITH LUX-VALVE PLUS IN
THE ASIA-PACIFIC REGION
-
2023.08.04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
-
2023.08.01
Articles of Association
-
2023.07.07
EARLY FEASIBILITY STUDY OF LUX-VALVE PLUS PRE-SUBMISSION ACCEPTED BY THE FDA
-
2023.07.05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
-
2023.06.05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
-
2023.05.31
POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING HELD ON MAY 31, 2023